Communications mentioning Evusheld between Charlotte Taylor and the Chief Medical Officer
Dear Department of Health and Social Care,
For the period 1 July 2022 to 6 September please provide:
All papers, emails (whether a primary preparer, recipient or cc’d) or other electronic communications between Charlotte Taylor of the Antivirals and Therapeutics Taskforce and the Chief Medical Officer in which Evusheld (i.e. the combination of tixagevimab and cilgavimab, AZD7442 or any other name that is used by the DHSC for this) is mentioned.
Yours faithfully,
Louise Bicknell
Dear Ms Bicknell,
Please find attached the Department of Health and Social Care's response
to your recent FOI request (our ref: FOI-1425462).
Yours sincerely,
Freedom of Information Team
Department of Health and Social Care
We work to defend the right to FOI for everyone
Help us protect your right to hold public authorities to account. Donate and support our work.
Donate Now
Louise Bicknell left an annotation ()
Refined request submitted to replace this